Sponsors and CROs choosing a randomization and trial supply management (RTSM, also called IRT) system for interventional trials.
Scope Sponsors and CROs choosing an RTSM/IRT system to randomize participants and manage investigational product supply in interventional trials. Site-side pharmacy tools and stand-alone supply planning software are out of scope.
These notes describe the products in the RTSM / IRT guide.
Almac IXRS 3
Best for
Sponsors who also use Almac for clinical packaging and distribution and want IRT, forecasting and logistics from one group
What to consider
Almac's IXRS 3 links to Almac's own clinical supply, SupplyWise forecasting and distribution services, and supports direct-to-patient workflows. Almac reports about 2,000 trials run on IXRS. Its public pages give no build timeline, name few randomization methods and show no named security certification.
Sponsors with complex randomization schemes, including minimization, who may also use YPrime eCOA
What to consider
YPrime names more randomization methods than any other vendor here, from permuted blocks to Pocock-Simon minimization, and publishes short build times. Its public IRT page does not describe supply forecasting or direct-to-patient shipping, and we found no named security certification.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Almac IXRS 3 vs YPrime IRT (RTSM / IRT): category feature evidence and sources. Products are not ranked.
Category feature
Almac IXRS 3
YPrime IRT
Randomization and blindingFeature definitions
Supported
Randomization or blinding workflows are stated.
Extended support
Named allocation methods include minimization or dynamic allocation.
Almac IXRS 3
Supported
Almac describes simple to complex adaptive designs with enrollment caps, cohorts and blinding protection, but does not name allocation methods.
Adaptive designs and blinding protection establish base support; allocation methods are not named.
YPrime IRT
Extended support
YPrime names permuted block and stratified randomization, dynamic allocation and minimization (Pocock and Simon), stratum caps and conditional re-randomization.
Named methods include permuted blocks, dynamic allocation and minimization.
Trial supply managementFeature definitions
Supported
Drug inventory, dispensing, shipping or resupply workflows are documented.
Extended support
Supply forecasting and direct-to-patient delivery (shipping or dispensing) are both documented.
Almac IXRS 3
Extended support
IXRS 3 documents resupply strategy, expiry and depot management, Almac's SupplyWise integrates demand forecasting with the IRT, and an Almac datasheet (Clinical Leader, August 2025) describes direct-to-patient workflows.
Resupply and SupplyWise forecasting combine with documented direct-to-patient workflows.
YPrime IRT
Supported
The IRT page covers inventory, orders, resupply, kit replacement and depot rules, but does not describe supply forecasting or direct-to-patient shipping.
Visual study build is described; a build timeline and mid-study change process are not published.
YPrime IRT
Supported
YPrime cites build to go-live in under four weeks for an early-phase oncology trial, about a week for the simplest designs, and self-service routine changes that take effect immediately.
Build timelines and immediately effective routine changes are stated; uninterrupted live use is not explicit.
Integrations and platformFeature definitions
Supported
Integration or data exchange with another system or application is described.
Extended support
Integration with a clinical-trial application plus an API for integration are both stated.
Almac IXRS 3
Extended support
Almac lists pre-built connectors and REST, SOAP and secure file integrations with EDC, CTMS, clinical supplies and central labs, but has no EDC or eCOA of its own.
Trial-system integrations establish base support; an API is not stated in this note.
Compliance and security evidenceFeature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Almac IXRS 3
Supported
Almac states its IXRS University training module is validated and 21 CFR Part 11 compliant; we found no named ISO 27001 or SOC 2 attestation for Clinical Technologies.